Useful Articles

Selank and Semax: Cognitive Peptide Research Overview
Selank and Semax represent a complementary pair of neuropeptides with documented clinical use in Russia and growing international research interest. Selank's GABAergic and anxiolytic mechanism provides research tools for stress response and anxiety biology, while Semax's BDNF/NGF-upregulating and neuroprotective profile addresses cognitive function and neurological injury research. Both have more developed human pharmacology profiles than most research peptides due to their Russian clinical approval history. For researchers investigating cognitive neuroscience, neuroprotection, or stress-cognition interactions, they provide mechanistically distinct tools with established behavioral pharmacology literature. Read more...
BPC-157 and TB-500: Combined Research Models
The scientific rationale for studying BPC-157 and TB-500 in combination rests on their complementary mechanisms targeting sequential steps in tissue repair: BPC-157 addresses vascular supply and extracellular matrix synthesis, while TB-500 addresses cell migration and cytoskeletal dynamics. Direct combination research remains an active but still developing area of the literature, with published rodent models providing preliminary evidence of additive effects in musculoskeletal and wound healing contexts. For researchers designing combination studies, careful attention to timing, dosing rationale, and mechanistic controls will produce the most interpretable data. Read more...
SS-31: Mitochondrial Targeted Peptide Research Overview
SS-31 represents the most advanced mitochondria-targeted research peptide currently available, with a defined molecular mechanism (cardiolipin binding and stabilization), extensive preclinical literature across cardiac, renal, muscle, and neurological models, and an active clinical trial program that provides human pharmacokinetic context. For researchers investigating mitochondrial dysfunction, oxidative stress, cellular aging, or organ-specific mitochondrial pathology, SS-31 provides a precisely targeted research tool with one of the most thoroughly characterized mechanisms in the mitochondria-directed peptide category. Read more...
Thymosin Alpha-1: Immune Modulation Research Overview
Thymosin Alpha-1 occupies a unique position in the research peptide landscape as a compound with both a robust preclinical literature and substantial clinical trial experience spanning infectious disease, oncology, and immunology. Its TLR2/9 mechanism, T-cell maturation activity, and dendritic cell activation profile provide mechanistically defined research tools for immunology investigators. Post-COVID research has generated a significant new body of publications, and ongoing interest in cancer immunology and vaccine adjuvant applications continues to produce primary research. For researchers investigating innate and adaptive immune function, Tα1 remains one of the most thoroughly... Read more...
Retatrutide: Next-Generation Triple Agonist Research Overview
Retatrutide represents the leading edge of metabolic peptide research in 2026 — a triple receptor agonist with Phase 2 clinical data showing weight reduction exceeding any previously reported pharmacological intervention. Its unique glucagon receptor component adds hepatic and thermogenic mechanisms absent in approved GLP-1-class compounds, and its Phase 3 program is generating some of the most closely watched data in contemporary metabolic medicine research. For researchers investigating incretin pathway biology, adipose tissue metabolism, or liver disease models, Retatrutide provides a mechanistically distinct research tool from currently available compounds. Read more...
Research Peptides in Europe 2026: Regulatory Framework for Researchers
The European regulatory framework for research peptides distinguishes clearly between research use — which is legal, established, and essential to the biomedical research ecosystem — and therapeutic or clinical use, which requires formal drug approval pathways. EU-registered suppliers operating with research-only designations, full COA documentation, and no therapeutic claims provide researchers with compliant access to investigational compounds within this framework. The 2026 US regulatory development has increased global awareness of research peptides but does not alter the EU framework. European researchers can continue to procure research peptides through established channels... Read more...
GHK-Cu (Copper Peptide): Research Overview
GHK-Cu is one of the most thoroughly investigated tripeptides in regenerative biology research. Its documented association with modulation of thousands of human genes, combined with consistent in vitro findings on collagen synthesis, wound healing, and anti-inflammatory signaling, has sustained research interest across multiple decades and research domains. The age-dependent decline in plasma GHK-Cu concentrations provides a physiological rationale for investigating exogenous administration in aging-related research models. As search interest has surged in 2025–2026, GHK-Cu has transitioned from a niche compound to one of the most discussed peptides in longevity and... Read more...
CJC-1295 No DAC vs CJC-1295 with DAC: Understanding the Difference
CJC-1295 No DAC and CJC-1295 with DAC share a GHRH receptor-binding backbone but differ fundamentally in pharmacokinetic behavior. The No DAC form produces short-duration pulsatile GH stimulation; the DAC form produces sustained, days-long GH and IGF-1 elevation via albumin binding. Selecting the correct form is not a minor methodological detail — it determines the fundamental GH secretion pattern in the experimental model and directly affects the interpretability and reproducibility of results. Researchers should verify compound identity by molecular weight and half-life before initiating protocols. Read more...
MOTS-C and Mitochondrial Research: An Overview
MOTS-C occupies a unique position in the peptide research landscape as a mitochondria-encoded signaling peptide with documented effects on AMPK pathways, metabolic regulation, and age-associated functional parameters in preclinical models. Its identification expanded the known biology of the mitochondrial genome and opened new research directions in mitochondrial-nuclear communication. As a relatively newly characterized peptide, it represents a high-interest compound in longevity and metabolic research with a publication record that continues to grow rapidly. Read more...
Peptide Storage and Handling in Laboratory Settings
Correct peptide storage and handling is not a secondary consideration — it is a prerequisite for experimental validity. Lyophilized peptides stored at −20°C with single-use aliquots prepared at reconstitution, using appropriate pharmaceutical-grade solvents, will retain their characterized purity through the duration of a research program. Departures from these practices introduce uncontrolled variables that no downstream analytical correction can address. All NordBioLab products are supplied with batch-specific COA documentation and recommended storage conditions. Contact us at info@nordbiolab.com for compound-specific handling guidance. Read more...
CJC-1295 and Ipamorelin: Research Applications in Growth Hormone Pathway Studies
CJC-1295 and Ipamorelin represent complementary tools for investigating the growth hormone secretion axis through two distinct receptor pathways. Their combined use in research models allows investigators to examine dual-pathway GH stimulation with a well-characterized selectivity profile. The published literature on both compounds is peer-reviewed and spans pituitary function, body composition, and aging research domains. NordBioLab supplies CJC-1295 and Ipamorelin as research-grade lyophilized peptides with ≥98% purity (HPLC verified) and full COA documentation per batch. Read more...
What is Epithalon? Longevity and Telomere Research Summary
Epithalon occupies a unique position in longevity research — a tetrapeptide with a concentrated but geographically specific publication record, centered on telomere biology, pineal function, and aging models. Its telomerase activation findings have attracted broad scientific attention, while independent replication remains an active area of need. For researchers investigating cellular aging mechanisms, it represents a compound with a defined molecular target and an established, if narrow, experimental literature. Read more...
TB-500 Peptide: Mechanisms Studied in Research
TB-500 represents a well-characterized synthetic fragment of one of the most abundant intracellular proteins in mammalian biology. Its actin-binding mechanism has generated research interest across connective tissue, cardiovascular, ocular, and inflammatory models. The publication record is substantial, with contributions from research groups across multiple organ system contexts. Read more...
Tirzepatide vs Semaglutide: A Research Comparison
Semaglutide and tirzepatide share incretin pathway mechanisms but differ fundamentally in receptor targeting. Tirzepatide's dual GIP/GLP-1 mechanism has generated significant research interest, with published clinical data suggesting differential outcomes in metabolic parameter models compared to GLP-1 monotherapy. Both remain active areas of investigation across metabolic, cardiovascular, and adipose tissue research domains. NordBioLab supplies Tirzepatide as a research-grade lyophilized compound with ≥98% purity (HPLC verified) and full COA documentation per batch. Read more...
What is BPC-157? A Research Overview
BPC-157 is one of the most extensively studied synthetic peptides in preclinical research, with a broad publication record across gastrointestinal, musculoskeletal, and neurological research domains. Its stability profile and multi-system activity have made it a compound of sustained scientific interest. NordBioLab supplies BPC-157 as a research-grade lyophilized powder with ≥98% purity (HPLC verified) and full COA documentation available per batch. Read more...